Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Lipid Disorder Treatment Market Expected To Grow In Terms Of Size?

Over the past few years, the lipid disorder treatment market has seen rapid expansion. It’s forecasted to grow from $10.69 billion in 2024 to $12.06 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.9%. The historic growth can be tied back to factors such as an increase in sedentary lifestyles, a growing working population, rising awareness about the disorder and associated treatments, an influx in desk-based employment, and a surge in familial combined hyperlipidemia diagnoses.

The market for lipid disorder treatment is forecast to experience significant expansion in the forthcoming years, swelling to a value of $18.82 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.8%. This predicted growth during the estimated period is largely due to mounting instances of obesity and high cholesterol, escalating prevalence of cardiovascular diseases, a rising trend of high cholesterol resulting in heart diseases, and an increasing demand for effective and secure treatments. A surge in alcohol and smoking also plays a supportive role in fueling this growth. The forecast period is also expected to witness several key trends including improved drug development technology, product innovation, surge in investment for business expansion, advanced treatment facility technology, and clinical advancements.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15600&type=smp

What Are The Primary Factors Supporting The Lipid Disorder Treatment Market Expansion?

The escalating incidences of obesity and high cholesterol are likely to stimulate the expansion of the lipid disorder treatment market in future. Obesity is defined by an excessive accumulation of body fat, while high cholesterol indicates raised cholesterol quantities in the blood. Both pose considerable health challenges. The rise in obesity and high cholesterol can be attributed to unhealthy eating habits, inactive lifestyles, genetic factors, and environmental impacts. The treatment of lipid disorders is crucial in managing obesity and high cholesterol as it amalgamates drug treatments, changes in lifestyle, strategies for weight regulation, patient instruction, and comprehensive care. For example, the World Obesity Atlas 2022, released by the UK-based nonprofit organization, World Obesity Federation, stated in May 2022 that one billion people around the world, including 1 in 5 women and 1 in 7 men, will be obese by 2030. This number is predicted to rise to 4 billion people or 51% of the global population by 2035. Hence, the increasing cases of obesity and high cholesterol are propelling the lipid disorder treatment market’s growth.

Which Segmentation Categories Are Highlighted In The Lipid Disorder Treatment Market Analysis?

The lipid disorder treatmentmarket covered in this report is segmented –

1) By Drug Type: Atorvastatin; Fluvastatin; Rosuvastatin; Simvastatin; Pravastatin; Other Drugs

2) By Indication: Familial Combined Hyperlipidemia; Familial Defective Apolipoprotein B-100; Familial Dysbetalipoproteinemia; Familial Hypertriglyceridemia; Heterozygous Familial Hypercholesterolemia; Other Indications

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

Subsegments:

1) By Atorvastatin: Generic Atorvastatin; Brand-Name Atorvastatin ( Lipitor)

2) By Fluvastatin: Generic Fluvastatin; Brand-Name Fluvastatin ( Lescol)

3) By Rosuvastatin: Generic Rosuvastatin; Brand-Name Rosuvastatin ( Crestor)

4) By Simvastatin: Generic Simvastatin; Brand-Name Simvastatin ( Zocor)

5) By Pravastatin: Generic Pravastatin; Brand-Name Pravastatin ( Pravachol)

6) By Other Drugs: Ezetimibe; Pcsk9 Inhibitors ( Alirocumab, Evolocumab); Fibrates ( Gemfibrozil, Fenofibrate); Niacin (Vitamin B3); Omega-3 Fatty Acids ( Icosapent Ethyl)

Which Trends Are Likely To Redefine Growth Paths In The Lipid Disorder Treatment Market?

Top companies in the lipid disorder treatment market are creating proprotein convertase subtilisin type 9 (PCSK9) inhibitors to meet the demand for more efficient, focused treatments for high cholesterol. These PCSK9 inhibitors control lipid disorders by improving the procedure of LDL cholesterol elimination from the blood, thus reducing the likelihood of cardiovascular incidents in patients at high risk. For example, in March 2024, the U.S. biotech company Regeneron Pharmaceuticals Inc. obtained permission for Praluent (alirocumab) injection from the FDA to treat heterozygous familial hypercholesterolemia (HeFH) in children aged 8 and over. Praluent injection stands out for its ability to prevent PCSK9 from attaching to the LDL receptor, which increases the number of LDL receptors on the surface of liver cells, leading to the faster removal of LDL and lower LDL-C levels in the bloodstream.

Which Organizations Are At The Forefront Of The Lipid Disorder Treatment Market?

Major companies operating in the lipid disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Fresenius SE & Co. KGaA, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline Plc, Wockhardt Ltd., Eli Lilly and Company, Amgen Inc., Boehringer-Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Kaneka Corporation, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, Kowa Pharmaceuticals America Inc., Concord Biotech Limited, Biocon Ltd., Ranbaxy Laboratories Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Lipid Disorder Treatment Market?

North America was the largest region in the lipid disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15600&type=smp

Browse Through More Reports Similar to the Global Lipid Disorder Treatment Market 2025, By The Business Research Company

Phospholipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/phospholipid-global-market-report

Lipid Panel Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-panel-testing-global-market-report

Lipid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model